Mokslo tyrimų ir inovacijų klinika, UAB - financials and debts
Company age: 5 y. 2 mo.
Mokslo tyrimų ir inovacijų klinika - Company finances
|
EUR
|
2021
From: 2021-07-26
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | 29,628 | 40,920 | 71,676 | 195,500 | 213,135 |
| Profit before tax | - | - | 10,669 | - | - |
| Net profit | 7,960 | 14,428 | 10,109 | 44,010 | 2,487 |
| Equity | 7,970 | 22,398 | 32,508 | 76,508 | 78,994 |
| Liabilities | 162 | 1,649 | 25,041 | 64,725 | 56,281 |
| Non-current assets | 0 | 0 | 21,134 | 88,434 | 67,982 |
| Current assets | 8,132 | 24,047 | 36,415 | 78,599 | 67,249 |
| Total assets | 8,132 | 24,047 | 57,549 | 167,033 | 135,231 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 3,173 | 36,349 | 36,032 |
| Social insurance contributions | - | - | 4,369 | 42,945 | 39,253 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | +38.1% | +75.2% | +172.8% | +9.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 97.9% | 60.0% | 17.6% | 26.3% | 1.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 99.9% | 64.4% | 31.1% | 57.5% | 3.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 26.9% | 35.3% | 14.1% | 22.5% | 1.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | 14.9% | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.1 | 0.8 | 0.8 | 0.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | 19,114 | 31,280 | 38,752 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Mokslo tyrimų ir inovacijų klinika - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-11-16 | 2023-11-19 | 326.29 |
| 2023-10-17 | 2023-10-24 | 21.84 |
Mokslo tyrimų ir inovacijų klinika - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Mokslo tyrimu ir inovaciju klinika, UAB (code 305839607) is a Private Limited Liability Company engaged in research and development in medical sciences. In 2025, the company generated revenue of €213.1K, up 9.0% year on year and nearly 197.4% above the 2023 level, showing a strong multi-year expansion in turnover. Profitability weakened markedly in 2025: net profit fell to €2.5K from €44.0K in 2024, and the net margin declined to 1.2% after 22.5% a year earlier. Despite this, the company remained profitable over the latest year. The balance sheet shows total assets of €135.2K, equity of €79.0K and liabilities of €56.3K at the end of 2025. Equity ratio stood at 58.4%, debt-to-equity at 0.71, and asset turnover at 1.58x. Return on equity was 3.1% and return on assets 1.8%. Revenue per employee was €42.6K, while profit per employee was €497, indicating that turnover remained solid but earnings were much thinner in 2025.